anti-CD272 antibody product blog
Tags: Antibody; Polyclonal Antibody; CD272; anti-CD272 antibody;
The CD272 n/a (Catalog #MBS837451) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s CD272 can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC) Paraffin, Western Blot (WB).IHC-P: 1:100-1:500
WB: 1:500-1:3000. Researchers should empirically determine the suitability of the CD272 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CD272 antibody with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemical staining of paraffin-embedded MDAMB468 xenograft using CD272 antibody at a dilution of 1:100)
Western Blot (WB) (Western blot analysis of 30 ug of whole cell lysate (A: Molt-4; B: Raji) using a 12 % SDS PAGE gel and CD272 antibody at a dilution of 1:1000)
Affinity purified Rabbit polyclonal CD272 antibody.
Biological Significance: BTLA expression is induced during activation of T cells, and BTLA remains expressed on Th1 cells but not Th2 cells. Like PD1 and CTLA4, BTLA interacts with a B7 homolog, B7H4. Cross-Reactivity: Human. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD272 are readily searchable from our website. Different antibodies against the same target such as CD272 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.